Intuitive Surgical stock is holding in the low $370s, far under its 52-week peak, while strong Q2 20

Compare SS Innovations vs. Intuitive Surgical in medical robotics—why SS Innovations may offer asymmetric upside, stronger growth, and better returns. Click to read.

Intuitive Surgical stock trades at $372.60 on Nasdaq as of August 30, 2026, while growing use of its

Intuitive Surgical is a biotechnology company developing tools for minimally invasive, robotics-assisted surgeries. It joined the Fortune 500 list for the first time in 2024. Five years after its 1995 founding, Intuitive introduced its da Vinci robot, a system using a 3D endoscopic camera and small arms operated by a surgeon at a console. According to the company, the da Vinci model has been used in 14 million procedures, including tonsillectomies and hysterectomies. Its da Vinci 5 model gained FDA approval in March 2024.

Intuitive Surgical stock is quoted around $372 on Nasdaq as of late August 2026, with the shares sit

Intuitive Surgical stock trades around $372 on Nasdaq as of August 29, 2026, after a recent pullback

Intuitive Surgical stock is holding a rich valuation backed by Q2 2026 procedure growth and strong c

Intuitive Surgical stock trades in the mid-$360s as of August 28, 2026, with strong Q2 2026 revenue

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $372.6, indicating a +1.51% shift from the previous trading day.

Intuitive Surgical (ISRG) quarterly earnings trends: EPS and revenue history versus Street estimates across all reported quarters, from SEC filings.

Intuitive Surgical stock is trading firmly after Q2 2026 results showed strong growth in da Vinci an

Intuitive Surgical stock is trading below recent highs even after double-digit Q2 growth and a newly